Companies / Vietnam
Vietnamese MoH To Force Price Cuts
April 2006 | Company Finance AlertEarlier in the year, the Vietnamese government investigated drug pricing practices in the country after prices for some medicines had unauthorised increases of between 5% to 200%. The companies involved have claimed that price rises were necessary due to the expenditure involved upgrading production lines to adhere to GMP, while high oil prices and the deprecation of the US dollar against the Euro have raised costs.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
